A tiny French study on hydroxychloroquine caught Trump's eye. He is touting it non-stop. But the professional society that published the study now has "concerns" about the methodology and says the article "does not meet the Society’s expected standard."

A tiny French study on hydroxychloroquine caught Trump's eye. He is touting it non-stop. But the professional society that published the study now has "concerns" about the methodology and says the article "does not meet the Society’s expected standard." https://t.co/2yZT7y7mhY pic.twitter.com/oqxp7CH6pj

— Marshall Cohen (@MarshallCohen) April 6, 2020